Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Xiaoan Li, Tiantian Guo, Qian Feng, Tiantian Bai, Lei Wu, Yubo Liu, Xu Zheng, Jianzhong Jia, Jin Pei, Shaoping Wu, Yiming Song & Yongmin Zhang. (2022) Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs. European Journal of Medicinal Chemistry 228, pages 114035.
Crossref
Crossref
Carlos A. Cañas, Felipe Cañas, Mario Bautista-Vargas & Fabio Bonilla-Abadía. (2021) Role of Tissue Factor in the Pathogenesis of COVID-19 and the Possible Ways to Inhibit It. Clinical and Applied Thrombosis/Hemostasis 27, pages 107602962110039.
Crossref
Crossref
Qiuzhe Wei, Jing Wang, Wei Shi, Bo Zhang, Huiwen Jiang, Mengyi Du, Heng Mei & Yu Hu. (2019) Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe. Acta Biomaterialia 90, pages 324-336.
Crossref
Crossref
Zhi-Bing Ou, Chun-Mu Miao, Ming-Xin Ye, Ding-Pei Xing, Kun He, Pei-Zhi Li, Rong-Tao Zhu & Jian-Ping Gong. (2017) Investigation for role of tissue factor and blood coagulation system in severe acute pancreatitis and associated liver injury. Biomedicine & Pharmacotherapy 85, pages 380-388.
Crossref
Crossref
Xiaojun Zhang, Peter W. Glunz, James A. Johnson, Wen Jiang, Swanee Jacutin-Porte, Vladimir Ladziata, Yan Zou, Monique S. Phillips, Nicholas R. Wurtz, Brandon Parkhurst, Alan R. Rendina, Timothy M. Harper, Daniel L. Cheney, Joseph M. Luettgen, Pancras C. Wong, Dietmar Seiffert, Ruth R. Wexler & E. Scott Priestley. (2016) Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa–Tissue Factor Complex. Journal of Medicinal Chemistry 59:15, pages 7125-7137.
Crossref
Crossref
Jiabin Yang, Guoqiang Su, Yu Ren & Yang Chen. (2015) Synthesis and in vitro anticoagulant activity of 3-(1H-imidazo[4,5-c]pyridin-2-yl)-1,5-diarylpyridin-2(1H)-one derivatives. Research on Chemical Intermediates 41:11, pages 8773-8783.
Crossref
Crossref
Xiaojun Zhang, Wen Jiang, Swanee Jacutin-Porte, Peter W. Glunz, Yan Zou, Xuhong Cheng, Alexandra H. Nirschl, Nicholas R. Wurtz, Joseph M. Luettgen, Alan R. Rendina, Gang Luo, Timothy M. Harper, Anzhi Wei, Rushith Anumula, Daniel L. Cheney, Robert M. Knabb, Pancras C. Wong, Ruth R. Wexler & E. Scott Priestley. (2013) Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors. ACS Medicinal Chemistry Letters 5:2, pages 188-192.
Crossref
Crossref
Xiaojun Zhang, Peter W. Glunz, Wen Jiang, Aaron Schmitt, Makenzie Newman, Frank A. Barbera, Jeffery M. Bozarth, Alan R. Rendina, Anzhi Wei, Xiao Wen, Karen A. Rossi, Joseph M. Luettgen, Pancras C. Wong, Robert M. Knabb, Ruth R. Wexler & E. Scott Priestley. (2013) Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF–FVIIa inhibitors. Bioorganic & Medicinal Chemistry Letters 23:6, pages 1604-1607.
Crossref
Crossref
Yu Tong, Jing Zhou, Meng Mao, Ju Gao & Lixing Yuan. (2012) Generation of bioactive recombinant Ancylostoma caninum anticoagulant peptide c2. Protein Expression and Purification 81:1, pages 49-54.
Crossref
Crossref
Ji-Eun Kim, Ki Jun Kim, Wonsik Ahn, Kyou-Sup Han & Hyun Kyung Kim. (2010) Local Anesthetics Inhibit Tissue Factor Expression in Activated Monocytes via Inhibition of Tissue Factor mRNA Synthesis. Clinical and Applied Thrombosis/Hemostasis 17:6, pages E4-E9.
Crossref
Crossref
Michelle J. Butler, William Chan, Andrew J. Taylor, Anthony M. Dart & Stephen J. Duffy. (2011) Management of the no-reflow phenomenon. Pharmacology & Therapeutics 132:1, pages 72-85.
Crossref
Crossref
Heng Mei, Wei Shi, Zhiqing Pang, Huafang Wang, Weiyue Lu, Xinguo Jiang, Jun Deng, Tao Guo & Yu Hu. (2010) EGFP-EGF1 protein-conjugated PEG–PLA nanoparticles for tissue factor targeted drug delivery. Biomaterials 31:21, pages 5619-5626.
Crossref
Crossref
Guillaume Karsenti, Yannick Le Manach, Stéphanie Bouvier, André Chaine & Chloé Bertolus. (2010) Statins: A new pharmacological agent for free flap surgery?. Journal of Plastic, Reconstructive & Aesthetic Surgery 63:5, pages 870-874.
Crossref
Crossref
Darin E. Jones & Michael S. South. (2010) Synthesis of a versatile 2 (1H)-pyrazinone core for the preparation of Tissue Factor-Factor VIIa inhibitors. Tetrahedron 66:14, pages 2570-2581.
Crossref
Crossref
Ludovic Drouet & Laurent Ripoll. (2006) Cibles des médicaments antithrombotiques. médecine/sciences 22:10, pages 887-894.
Crossref
Crossref
Matthew Adess, Robert Eisner, Sucha Nand, John Godwin, Harry L. MessmoreJrJr & William H. Wehrmacher. (2016) Thromboembolism in Cancer Patients: Pathogenesis and Treatment. Clinical and Applied Thrombosis/Hemostasis 12:3, pages 254-266.
Crossref
Crossref
L. Keith Scott & Steven A. Conrad. 2006. Wiley Encyclopedia of Biomedical Engineering. Wiley Encyclopedia of Biomedical Engineering.
Robert M. Scarborough, Anjali Pandey & Xiaoming Zhang. 2005. Annual Reports in Medicinal Chemistry Volume 40. Annual Reports in Medicinal Chemistry Volume 40
85
101
.
Shojiro Kadono, Akihisa Sakamoto, Yasufumi Kikuchi, Masayoshi Oh-eda, Naohiro Yabuta, Takaki Koga, Kunihiro Hattori, Takuya Shiraishi, Masayuki Haramura, Hirofumi Kodama, Toru Esaki, Haruhiko Sato, Yoshiaki Watanabe, Susumu Itoh, Masateru Ohta & Toshiro Kozono. (2004) Crystal structure of human factor VIIa/tissue factor in complex with peptide mimetic inhibitor. Biochemical and Biophysical Research Communications 324:4, pages 1227-1233.
Crossref
Crossref
Juliusz Mieszczanek, Lisa M. Harrison & Michael Cappello. (2004) Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa. Molecular and Biochemical Parasitology 137:1, pages 151-159.
Crossref
Crossref
John J. Parlow, Ravi G. Kurumbail, Roderick A. Stegeman, Anna M. Stevens, William C. Stallings & Michael S. South. (2003) Synthesis and X-ray crystal structures of substituted fluorobenzene and benzoquinone inhibitors of the tissue factor VIIa complex. Bioorganic & Medicinal Chemistry Letters 13:21, pages 3721-3725.
Crossref
Crossref
John J. Parlow, Ravi G. Kurumbail, Roderick A. Stegeman, Anna M. Stevens, William C. Stallings & Michael S. South. (2003) Design, Synthesis, and Crystal Structure of Selective 2-Pyridone Tissue Factor VIIa Inhibitors. Journal of Medicinal Chemistry 46:22, pages 4696-4701.
Crossref
Crossref
John J. Parlow, Anna M. Stevens, Roderick A. Stegeman, William C. Stallings, Ravi G. Kurumbail & Michael S. South. (2003) Synthesis and Crystal Structures of Substituted Benzenes and Benzoquinones as Tissue Factor VIIa Inhibitors. Journal of Medicinal Chemistry 46:20, pages 4297-4312.
Crossref
Crossref
John J. ParlowBrenda L. CaseThomas A. DiceRicky L. FentonMichael J. HayesDarin E. JonesWilliam L. NeumannRhonda S. WoodRhonda M. LachanceThomas J. GirardNancy S. NicholsonMichael ClareRoderick A. StegemanAnna M. StevensWilliam C. StallingsRavi G. KurumbailMichael S. South. (2003) Design, Parallel Synthesis, and Crystal Structures of Pyrazinone Antithrombotics as Selective Inhibitors of the Tissue Factor VIIa Complex. Journal of Medicinal Chemistry 46:19, pages 4050-4062.
Crossref
Crossref
John J. Parlow, Thomas A. Dice, Rhonda M. Lachance, Thomas J. Girard, Anna M. Stevens, Roderick A. Stegeman, William C. Stallings, Ravi G. Kurumbail & Michael S. South. (2003) Polymer-Assisted Solution-Phase Library Synthesis and Crystal Structure of α-Ketothiazoles as Tissue Factor VIIa Inhibitors. Journal of Medicinal Chemistry 46:19, pages 4043-4049.
Crossref
Crossref
John J Parlow & Michael S South. (2003) Synthesis of 2-pyridones as tissue factor VIIa inhibitors. Tetrahedron 59:39, pages 7695-7701.
Crossref
Crossref
Michael S South, Thomas A Dice, Thomas J Girard, Rhonda M Lachance, Anna M Stevens, Roderick A Stegeman, William C Stallings, Ravi G Kurumbail & John J Parlow. (2003) Polymer-Assisted solution-Phase (PASP) parallel synthesis of an α-Ketothiazole library as tissue factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters 13:14, pages 2363-2367.
Crossref
Crossref
Elliott M. Antman. (2003) Should Bivalirudin Replace Heparin During Percutaneous Coronary Interventions?. JAMA 289:7, pages 903.
Crossref
Crossref